Contemporary Pediatrics

  • Home
  • Contemporary Pediatrics

Contemporary Pediatrics Expert Clinical Advice for Today's Pediatrician

In her latest column for Contemporary Pediatrics, registered dietician Colleen Sloan, PA-C, RDN takes a look at pre-ga...
13/08/2025

In her latest column for Contemporary Pediatrics, registered dietician Colleen Sloan, PA-C, RDN takes a look at pre-game, mid-game, and post-game nutrition tips, as fall sports get ever closer.

Read this article from our August Back-to-School issue here: https://hubs.li/Q03CzP8B0

See below for any recent headlines you may have missed, and click each link for more. - FDA approves first generic iro...
13/08/2025

See below for any recent headlines you may have missed, and click each link for more.

- FDA approves first generic iron sucrose injection for iron deficiency anemia in . Read more: https://www.contemporarypediatrics.com/view/fda-approves-first-generic-iron-sucrose-injection-for-iron-deficiency-anemia-in-ckd

- FDA approves brensocatib to treat adolescents with non-cystic fibrosis bronchiectasis. Read more: https://www.contemporarypediatrics.com/view/fda-approves-brensocatib-to-treat-adolescents-with-non-cystic-fibrosis-bronchiectasis

- FDA accepts priority review for gepotidacin as oral treatment for gonorrhea. Read more: https://www.contemporarypediatrics.com/view/fda-accepts-priority-review-for-gepotidacin-as-oral-treatment-for-gonorrhea

The U.S. Food and Drug Administration has approved the first generic iron sucrose injection (Viatris) for treatment of i...
12/08/2025

The U.S. Food and Drug Administration has approved the first generic iron sucrose injection (Viatris) for treatment of iron deficiency anemia in CKD patients aged 2 years and older. https://hubs.li/Q03Ctvy70

BREAKING news: The federal agency has approved the first and only treatment for non-cystic fibrosis, with the decision...
12/08/2025

BREAKING news:

The federal agency has approved the first and only treatment for non-cystic fibrosis, with the decision to approve Insmed Incorporated's brensocatib (BRINSUPRI)10 mg and 25 mg tablets.

Full approval details: https://hubs.li/Q03Cn02Q0

If approved, gepotidacin (GSK) would be the first oral treatment option for uncomplicated urogenital gonorrhea in the Un...
12/08/2025

If approved, gepotidacin (GSK) would be the first oral treatment option for uncomplicated urogenital gonorrhea in the United States and could reduce reliance on injectable regimens. https://hubs.li/Q03ClHZR0

Tyra Bryant-Stephens, MD, and Richard Wong, DO, spoke with us to highlight issues with face in the school setting. T...
11/08/2025

Tyra Bryant-Stephens, MD, and Richard Wong, DO, spoke with us to highlight issues with face in the school setting. They provide practical examples of how to mitigate symptoms and what you should tell families as school approaches.

WATCH: https://hubs.li/Q03C8JFw0

In this article from our Back-to-School issue, Tanya Altmann, MD, FAAP, and Marina Salama, MD, discuss how pediatricians...
08/08/2025

In this article from our Back-to-School issue, Tanya Altmann, MD, FAAP, and Marina Salama, MD, discuss how pediatricians are uniquely positioned to support families during a new school year, and how they can monitor in children.

Full story: https://hubs.li/Q03BWHTP0

In a new video interview with Contemporary Pediatrics, Michael Haller, MD, professor and chief of Pediatric Endocrinolog...
08/08/2025

In a new video interview with Contemporary Pediatrics, Michael Haller, MD, professor and chief of Pediatric Endocrinology at the University of Florida explains inhaled insulin data and the benefits it can bring to the pediatric population for type 1 management.

This week, manufacturer MannKind Corporation announced that a supplemental Biologics License Application for Afrezza has been filed with the U.S. Food and Drug Administration with a decision expected in the fourth quarter of 2025.

Read and watch more on Afrezza and inhaled insulin, here: https://hubs.li/Q03BS0qG0

Pediatric obesity drug use increased after AAP guideline:The AAP guideline emphasized early evaluation and treatment of ...
07/08/2025

Pediatric obesity drug use increased after AAP guideline:

The AAP guideline emphasized early evaluation and treatment of obesity, including the recommendation of intensive health behavior and lifestyle treatment (IHBLT) as first-line therapy and pharmacotherapy for adolescents aged 12 years or older in select cases. The guidelines did not recommend pharmacotherapy for younger children unless individually warranted.

Read more on new research: https://hubs.li/Q03BMFDh0

From our August Back-to-School issue: As the return to the classrooms for gets ever closer, as do triggers for a vul...
06/08/2025

From our August Back-to-School issue:

As the return to the classrooms for gets ever closer, as do triggers for a vulnerable population.

In this featured article, Tyra Bryant-Stephens, MD of Children's Hospital of Philadelphia and Richard Wong, DO of Phoenix Children's, discuss important reminders you can relay to parents as they come in for well visits prior to a new year. Additionally, the experts provide practice guidance for families and the children themselves that can aid in keeping asthma symptoms quiet in the classroom.

Read from our August issue here: https://hubs.li/Q03Bz1sh0

Address


Website

Alerts

Be the first to know and let us send you an email when Contemporary Pediatrics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Contemporary Pediatrics:

Shortcuts

  • Address
  • Alerts
  • Contact The Business
  • Claim ownership or report listing

  • Want your business to be the top-listed Media Company?

Share